Citigroup now needs a steady hand to bring the bank to its full potential, Dick Bove says.» Read More
Drugmakers eager to satisfy shareholders are wheeling, dealing, and in one case even making trades like a pro sports team looking to shake up its roster.
When asked how much he'd like to invest in seeding new activist funds, Icahn said investing $1 billion would be extremely immaterial to his firm.
Hedge fund manager Bill Ackman promised to pay a disgruntled ex-Herbalife executive as much as $3.60 million over the next 10 years, a report said.
Greenlight Capital supports IEX and holds a stake in it.
Bonds are pretty clearly a bad job, with returns relatively meager and prices set to fall, but yield-seeking investors keep pushing money their way.
And it all has to do with how earnings are valued, the founder of the Vanguard group told CNBC.
The bull market is seeing the equivalent of its first gray hairs and the proof is in Tuesday's blast of merger activity.
Valeant Pharmaceuticals and Bill Ackman are proposing a cash-and-stock deal for Allergan that could be worth about $45 billion.
After an early April swoon, most stocks have recovered. However, there are still 8 of them that are down 10 percent or more. Investors are suffering.
Ocwen Financial is suspected of 'self-dealing' by regulators and accused of overcharging borrowers and investors to auction off foreclosed properties.
The strong performance of the so-called "fragile five" currencies has marked a return to favor for the so-called carry trade.
Making loans for China's smaller businesses more available would likely resolve the shadow banking hobbling the financial system, Minsheng Banking's vice chairman said.
Pharmaceutical industry observers have been waiting for a rush of deals for months - and they might have finally arrived.
Dan Loeb continued his battle with Sotheby's on Monday with a new letter promoting Third Point's board nominees over the art house's slate.
U.S. subprime auto lenders are "exercising more caution," especially when it comes to higher-risk customers, according to Moody's.
For the first time in several years, Europe's IPO market looks hotter than America's. It could last for some time.
Japan overhauled the world's biggest public pension fund in a push toward Prime Minister Shinzo Abe's goal of a more aggressive investment strategy.
Is there a specific rate of return for an investment that should set off alarm bells in your head?
Barclays is planning to exit large parts of its metals, agricultural and energy business in a move expected to be announced this week.
A U.S. appeals court is set hear a case whose outcome could make it harder to prosecute insider trading and may jeopardize some guilty verdicts.
Get the best of CNBC in your inbox
Maybe it was the martini that helped Carl Icahn publicly support longtime nemesis Bill Ackman.
Stocks of SunEdison and Conn's jumped Tuesday on news that Greenlight Capital had opened new positions in them.
Happy Wednesday and welcome to the Morning Six-Pack, where we're always trying to beat analyst estimates.
Bonds are a bad job, with returns relatively meager and prices set to fall, but yield-seeking investors keep pushing money their way.
With the Fed paring back bond-buying, retirees are bracing for volatility, but financial advisors are not too concerned.
Retirees advise young people to start saving for retirement as early as possible to max out compounded-interest gains.